Cassian Yee, MD
Fred Hutchinson Cancer Research Center
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Using NY-ESO-1, a previously discovered antigen, Dr. Cassian Yee and Dr. Naomi Hunder, both of Fred Hutchinson Cancer Research Center, are using a new technique to treat patients with late stage ovarian cancer. T cells are collected from eligible patients and responder T cells are enhanced. These are given back to the patient through IV, where the patient’s immune system will recognize these cells and use them to fight the existing cancer.